Document is current
Any future updates will be listed below
-
Authors
Tapia, Jose C. https://orcid.org/0000-0001-6545-8862
Gavira, Javier
Anguera, Georgia
Sanchez, Sofia
Romano, Alejandra
Bosma, Freya
Molina, Alejandra
Sanz-Beltran, Judit
Martin-Lorente, Cristina
Algaba, Fernando
Maroto, Pablo
- License Information
-
More Information
Article History
Received: 13 December 2023
Accepted: 19 January 2024
First Online: 29 February 2024
Declarations
:
: Javier Gavira: Speakers’ Bureau: Astellas, LEO Pharma; travel, accommodations, expenses: Ipsen, BMS, Novartis, Roche. Jose C. Tapia: travel, accommodations, expenses: Merck, Pfizer, Roche, and Lily/Genentech. Georgia Anguera: Speakers’ Bureau: Astellas Pharma, Ipsen, Bristol Myers Squibb, Merck/Pfizer, Leo pharma; Advisory: Merck; travel, accommodations, expenses: Merck, Ipsen, Bristol Myers Squibb. Pablo Maroto: consulting or advisory role: Astellas Pharma, Ipsen, BMS, Merck/Pfizer, Bayer, Janssen; travel, accommodations, expenses: Merck/Pfizer, Bayer. No other potential conflicts of interest were reported for others authors.
: This study was conducted in accordance with the ethical guidelines of the Declaration of Helsinski. All patients gave informed consent to allow use their data for this research.
